Biotransformation of Ginsenoside Rb1 to Ginsenoside CK by Strain XD101: a Safe Bioconversion Strategy

Yunyun Jiang,Weina Li,Daidi Fan
DOI: https://doi.org/10.1007/s12010-021-03485-0
2021-02-24
Applied Biochemistry and Biotechnology
Abstract:Ginsenoside Rb1 is the main predominant component in <i>Panax</i> species. In this study, an eco-friendly and convenient preparation method for ginsenoside CK has been established, and five strains of β-glucosidase-producing microorganisms were screened out from the soil of a <i>Panax notoginseng</i> planting field using Esculin-R2A agar. <i>Aspergillus niger</i> XD101 showed that it has excellent biocatalytic activity for ginsenosides; one of the isolates can convert ginsenoside Rb1 to CK using extracellular enzyme from the mycelium. Mycelia of <i>A. niger</i> were cultivated in wheat bran media at 30 °C for 11 days. By the removal of mycelia from cultured broth, enzyme salt fractionation by ammonium sulfate (70%, v/v) precipitation, and dialysis, sequentially, crude enzyme preparations from fermentation liquid supernatant were obtained. The enzymatic transformed Rb1 as the following pathways: Rb1→Rd→F2→CK. The optimized reaction conditions are at reaction time of 72 h, in the range of pH 4–5, and temperature of 50–60 °C. Active minor ginsenosides can be obtained by a specific bioconversion via <i>A. niger</i> XD101 producing the ginsenoside-hydrolyzing β-glucosidase. In addition, the crude enzyme can be resulted in producing ginsenoside CK via conversion of ginsenoside Rb1 at high conversion yield (94.4%). FDA generally regarded, <i>A.niger</i> as safe microorganism. Therefore, these results indicate that <i>A. niger</i> XD10 may provide an alternative method to prepare ginsenoside CK without food safety issues in the pharmaceutical industry.
biotechnology & applied microbiology,biochemistry & molecular biology
What problem does this paper attempt to address?